News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Photo of Ilya Tsimafeyeu taken from bucare.org
Oct 25, 2023, 17:52

Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival

Ilya Tsimafeyeu, Director at Bureau of Cancer Re­search Russia, shared on Facebook:

“Our study: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival.”

Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival

 

For further information click here.
Source: Ilya Tsimafeyeu/Facebook

cancer Ilya Tsimafeyeu metastatic renal cell carcinoma nivolumab OncoDaily
Special Coverage
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research
Blog
May 9, 2025, 06:47
Wade Swenson: Addressing the rural cancer care crisis in Minnesota requires innovative solutions
Oncolibrary
May 9, 2025, 06:27
Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated
Insight
May 9, 2025, 06:07
Oguna Kasam: Landmark Achievement for Kenya - Aga Khan University Hospital Delivered First Lutetium 177 Therapy
Drugs
May 9, 2025, 05:39
Erika Hamilton: Zanidatamab Combination Shows Promising Results in HR+/HER2+ Metastatic Breast Cancer
Science
May 9, 2025, 04:20
Valerie Yang: What started out as an academic collaboration is now available as a treatment option for soft tissue sarcoma patients
Cancer Types
May 9, 2025, 02:44
Medulloblastoma: Breakthroughs in Types, Symptoms, Diagnosis, Treatment, and 2025 Advances in Care
Blog
May 9, 2025, 01:36
Laura Bukavina: We walk to fuel research and hope
Blog
May 8, 2025, 18:13
Highlights from the NCCN Oncology Policy Summit 2025